Total submissions: 18
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000082249 | SCV000114198 | likely benign | not specified | 2015-03-06 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000082249 | SCV000246994 | uncertain significance | not specified | 2014-05-01 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000351974 | SCV000381452 | likely benign | Joubert syndrome 5 | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. |
Illumina Laboratory Services, |
RCV000402012 | SCV000381453 | uncertain significance | Meckel syndrome, type 4 | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. |
Illumina Laboratory Services, |
RCV000307654 | SCV000381454 | uncertain significance | Leber congenital amaurosis 10 | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. |
Illumina Laboratory Services, |
RCV000366483 | SCV000381455 | likely benign | Senior-Loken syndrome 6 | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. |
Illumina Laboratory Services, |
RCV000408211 | SCV000381456 | likely benign | Bardet-Biedl syndrome 14 | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. |
Center for Pediatric Genomic Medicine, |
RCV000442189 | SCV000511628 | likely benign | not provided | 2016-09-15 | criteria provided, single submitter | clinical testing | Converted during submission to Likely benign. |
Labcorp Genetics |
RCV001082252 | SCV000554515 | benign | Familial aplasia of the vermis; Meckel-Gruber syndrome; Nephronophthisis | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000442189 | SCV000566049 | likely benign | not provided | 2020-01-29 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 28127548, 27166760) |
Ce |
RCV000442189 | SCV000780444 | likely benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | CEP290: BP4, BS2 |
Genome- |
RCV000408211 | SCV001781512 | uncertain significance | Bardet-Biedl syndrome 14 | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000351974 | SCV001781513 | uncertain significance | Joubert syndrome 5 | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000402012 | SCV001781514 | uncertain significance | Meckel syndrome, type 4 | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000366483 | SCV001781515 | uncertain significance | Senior-Loken syndrome 6 | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000082249 | SCV002500532 | likely benign | not specified | 2022-03-20 | criteria provided, single submitter | clinical testing | Variant summary: CEP290 c.4237G>C (p.Asp1413His) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.0023 in 229244 control chromosomes in the gnomAD database, including 2 homozygotes. The observed variant frequency is approximately 2.0 fold of the estimated maximal expected allele frequency for a pathogenic variant in CEP290 causing Meckel Syndrome Type 4 phenotype (0.0011), strongly suggesting that the variant is benign. To our knowledge, no penetrant association of c.4237G>C in individuals affected with Meckel Syndrome Type 4 and no experimental evidence demonstrating its impact on protein function have been reported. Nine clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and a majority consensus as likely benign/benign (n=6) (VUS, n=3). Based on the evidence outlined above, the variant was classified as likely benign. |
Prevention |
RCV004528298 | SCV000314551 | likely benign | CEP290-related disorder | 2023-02-10 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Natera, |
RCV001273070 | SCV001455657 | likely benign | Leber congenital amaurosis | 2020-04-17 | no assertion criteria provided | clinical testing |